Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil

Expansion of Cooperation With Diabetes Leader Novo Nordisk

DÜSSELDORF, Germany, January 11 - The Gerresheimer Group has set up a new facility for medical
plastic systems in Indaiatuba (Brazil). The plant is to commence operations
early in 2010. On the basis of a long-term cooperation agreement with Novo
Nordisk, components will be produced with state-of-the-art technology for
insulin pen systems for diabetics.

Insulin pens are drug-delivery devices in ball-point pen
format which allow diabetes patients to inject themselves with the regularly
required insulin dose safely and almost painlessly. Novo Nordisk as the
world's leading insulin producer has contracted Gerresheimer to manufacture
components for its insulin pens. Novo Nordisk has a large insulin plant in
Brazil which will in future be supplied locally by the new technology center
of the Gerresheimer Group. For Gerresheimer this is already the fourth
production plant in South America in addition to two existing plants for
standardized pharma plastic packaging in Brazil and one in Argentina.

Apart from the new production facility in Brazil, Gerresheimer
already has two other production facilities for pen systems in Europe.

"Cooperation with Novo Nordisk in Brazil is of substantial
strategic importance for us. We support the customer in developing new
markets and at the same time expand our technological base in South America,"
says Gerresheimer CEO Dr. Axel Herberg.

About Gerresheimer

Gerresheimer employs around 10,000 people in 40 locations in
Europe, America and Asia. In the financial year 2008, worldwide sales totaled
EUR1.06bn. The product portfolio ranges from pharma­ceu­tical vials made of
glass and plastic through to complex drug-delivery systems for the pharma &
healthcare industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and application of medications. The
Group enjoys a leading position in markets which are characterized by high
technical and regulatory barriers.

    Contact Press

    Burkhard Lingenberg
    Director Corporate Communication & Marketing
    Phone +49-211-6181-250
    Fax +49-211-6181-241
    e-mail b.lingenberg@gerresheimer.com

    Contact Investor Relations

    Anke Linnartz
    Director Corporate Investor Relations
    Phone +49-211-6181-314
    Fax +49-211-6181-121
    e-mail a.linnartz@gerresheimer.com

Contact Press: Burkhard Lingenberg, Director Corporate Communication & Marketing, Phone +49-211-6181-250, Fax +49-211-6181-241, e-mail b.lingenberg at gerresheimer.com . Contact Investor Relations: Anke Linnartz, Director Corporate Investor Relations, Phone +49-211-6181-314, Fax +49-211-6181-121, e-mail a.linnartz at gerresheimer.com .